{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:59:29Z","timestamp":1791082769923,"version":"4.1.0"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Despite the successful implementation of prophylactic vaccines, hepatitis B virus (HBV) continues to affect over 350 million individuals globally. It remains a predominant etiology of end-stage liver pathologies, including liver cirrhosis and hepatocellular carcinoma (HCC). While nucleos(t)ide analog (NUC) therapies effectively suppress viral replication, functional cure is achieved in less than 1% of patients annually. Given that viral clearance fundamentally requires reconstitution of antiviral immunity, emerging therapeutic paradigms necessitate combinatorial strategies integrating direct-acting antiviral agents with immunomodulatory interventions. Substantial research efforts have been directed toward elucidating the immunological mechanisms underlying HBV persistence during chronic infection. This review systematically summarizes the functional impairment of innate immune populations and unconventional T cell subsets across distinct clinical phases of chronic HBV infection, and characterizes longitudinal immune reconstitution patterns following antiviral treatments. Our review identifies potential immunological biomarkers and provides a mechanistic framework for developing targeted immunotherapies to achieve durable HBV control.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1611976","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:27:04Z","timestamp":1751606824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection"],"prefix":"10.3389","volume":"16","author":[{"given":"Yiwen","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet Lond Engl"},{"key":"B2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New approaches to chronic hepatitis B","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1075916","article-title":"Hepatitis B functional cure and immune response","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.coviro.2021.04.003","article-title":"Innate immunity and HBV persistence","volume":"49","author":"Chiale","year":"2021","journal-title":"Curr Opin Virol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: An update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.04.016","article-title":"Development and function of dendritic cell subsets","volume":"40","author":"Mildner","year":"2014","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.10.002","article-title":"Decoding the heterogeneity of human dendritic cell subsets","volume":"41","author":"Villar","year":"2020","journal-title":"Trends Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2016.96","article-title":"Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT\/ERK\/P38 pathway: A possible mechanism of hepatitis B virus persistence","volume":"96","author":"Li","year":"2016","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.06.001","article-title":"HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection","volume":"1","author":"Ferrando-Martinez","year":"2019","journal-title":"JHEP Rep Innov Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026315","article-title":"Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells","volume":"6","author":"Vincent","year":"2011","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00011-012-0493-z","article-title":"Downregulation of TLR7\/9 leads to deficient production of IFN-\u03b1 from plasmacytoid dendritic cells in chronic hepatitis B","volume":"61","author":"Xu","year":"2012","journal-title":"Inflammation Res Off J Eur Histamine Res Soc Al"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.04.031","article-title":"HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells","volume":"46","author":"Xu","year":"2009","journal-title":"Mol Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015324","article-title":"Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function","volume":"6","author":"Woltman","year":"2011","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-016-9763-0","article-title":"Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection","volume":"10","author":"Sukriti","year":"2016","journal-title":"Hepatol Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00112","article-title":"Circulating and hepatic BDCA1+, BDCA2+, and BDCA3+ dendritic cells are differentially subverted in patients with chronic HBV infection","volume":"10","author":"Ouaguia","year":"2019","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1053\/j.gastro.2012.08.046","article-title":"Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection","volume":"143","author":"Martinet","year":"2012","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12967-020-02584-6","article-title":"Expanded circulating follicular dendritic cells facilitate immune responses in chronic HBV infection","volume":"18","author":"Li","year":"2020","journal-title":"J Transl Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.221275","article-title":"Plasmacytoid dendritic cell function and cytokine network profiles in patients with acute or chronic hepatitis B virus infection","volume":"131","author":"Li","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000625","article-title":"HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients\u2019 clinical stage","volume":"9","author":"Dumolard","year":"2025","journal-title":"Hepatol Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00939-1","article-title":"Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction","volume":"19","author":"Zhao","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/413952","article-title":"Hepatitis B e antigen seroconversion is related with the function of dendritic cells in chronic hepatitis B virus infection","volume":"2014","author":"Lin","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12865-023-00571-2","article-title":"Function and autophagy of monocyte-derived dendritic cells is affected by hepatitis B virus infection","volume":"24","author":"Xu","year":"2023","journal-title":"BMC Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891424","article-title":"Expression of functional molecule on plasmacytoid dendritic cells is associated with HBsAg loss in HBeAg-positive patients during PEG-IFN \u03b1-2a treatment","volume":"13","author":"Cao","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.8161","article-title":"Predictive value of plasmacytoid dendritic cells and toll-like receptor-9 regarding the treatment efficacy of interferon-\u03b1 in HBeAg-positive chronic hepatitis B patients","volume":"18","author":"Chen","year":"2019","journal-title":"Exp Ther Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21340","article-title":"Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV","volume":"44","author":"van der Molen","year":"2006","journal-title":"Hepatol Baltim Md"},{"key":"B27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/jir.2018.0014","article-title":"Quantitation of plasmacytoid dendritic cells in chronic hepatitis B patients with HBeAg positivity during PEG-IFN and entecavir therapy","volume":"38","author":"Cao","year":"2018","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-004-6249-y","article-title":"Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans","volume":"24","author":"Duan","year":"2004","journal-title":"J Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.09.027","article-title":"Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression","volume":"78","author":"Gane","year":"2023","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2638","article-title":"Origin of monocytes and macrophages in a committed progenitor","volume":"14","author":"Hettinger","year":"2013","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.immuni.2013.08.007","article-title":"Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes","volume":"39","author":"Jakubzick","year":"2013","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314098","article-title":"Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1474853","article-title":"Monocyte-derived galectin-9 and PD-L1 differentially impair adaptive and innate immune response in chronic HBV infection and their expression remain unaltered after antiviral therapy","volume":"15","author":"Dey","year":"2024","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cellimm.2013.05.009","article-title":"Regulation of B7-H1 expression on peripheral monocytes and IFN-\u03b3 secretion in T lymphocytes by HBeAg","volume":"283","author":"Han","year":"2013","journal-title":"Cell Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2006.00746.x","article-title":"B7-H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels","volume":"13","author":"Geng","year":"2006","journal-title":"J Viral Hepat"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2762","article-title":"Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy","volume":"19","author":"Huang","year":"2014","journal-title":"Antivir Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2021.00496","article-title":"Soluble CD163 and CD163 expression on monocytes associated with chronic hepatitis B inflammation and HBsAg loss","volume":"10","author":"Xie","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01939-22","article-title":"Multifaceted defects in monocytes in different phases of chronic hepatitis B virus infection: Lack of restoration after antiviral therapy","volume":"10","author":"Dey","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2100831","article-title":"Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy","volume":"11","author":"Li","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000524","article-title":"Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-\u03b1 in patients with chronic hepatitis B","volume":"79","author":"Jiang","year":"2024","journal-title":"Hepatol Baltim Md"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa614","article-title":"Differential gene expression, irrespective of circulating hepatitis B surface antigen levels, between inactive carrier and nucleos(t)ide analogue-treated hepatitis B virus patients","volume":"225","author":"Montanari","year":"2022","journal-title":"J Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","article-title":"MDSC; the most important cell you have never heard of","volume":"40","author":"Tesi","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/0008-5472.CAN-06-3037","article-title":"The terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Gabrilovich","year":"2007","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1294-5","article-title":"Neutrophils and granulocytic myeloid-derived suppressor cells: Immunophenotyping, cell biology and clinical relevance in human oncology","volume":"61","author":"Dumitru","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: Markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.10.4367","article-title":"Expression and clinical significance of myeloid derived suppressor cells in chronic hepatitis B patients","volume":"15","author":"Lu","year":"2014","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2018.04.002","article-title":"Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients","volume":"42","author":"Lv","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B49","first-page":"1387","article-title":"the frequency of peripheral blood CD14(+)HLA-DR(-\/low) MDSCs is negatively correlated with the inflammation in patients with chronic hepatitis B","volume":"31","author":"Zhang","year":"2015","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi Chin J Cell Mol Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501362","article-title":"Polarization of monocytic myeloid-derived suppressor cells by hepatitis B surface antigen is mediated via ERK\/IL-6\/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection","volume":"195","author":"Fang","year":"2015","journal-title":"J Immunol Baltim Md 1950"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32331","article-title":"Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing","volume":"76","author":"Pal","year":"2022","journal-title":"Hepatol Baltim Md"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007690","article-title":"Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection","volume":"15","author":"Yang","year":"2019","journal-title":"PLoS Pathog"},{"key":"B53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","author":"Pallett","year":"2015","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70360","article-title":"Single-cell atlas of the peripheral immune response in patients with chronic hepatitis B","volume":"97","author":"Huang","year":"2025","journal-title":"J Med Virol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211838","article-title":"Monocytic MDSCs homing to thymus contribute to age-related CD8+ T cell tolerance of HBV","volume":"219","author":"Fang","year":"2022","journal-title":"J Exp Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15226","article-title":"Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy","volume":"49","author":"Pal","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15489","article-title":"Lower frequency of MDSCs was significantly related to functional cure in CHB patients treated with peginterferon","volume":"43","author":"Zhang","year":"2023","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.09.022","article-title":"Human natural killer cells: Form, function, and development","volume":"151","author":"Mace","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00057","article-title":"NK cells: A double-edged sword in chronic hepatitis B virus infection","volume":"4","author":"Maini","year":"2013","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","author":"Lunemann","year":"2014","journal-title":"J Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049135","article-title":"Natural killer cells are characterized by the concomitantly increased interferon-\u03b3 and cytotoxicity in acute resolved hepatitis B patients","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.20411\/pai.v3i1.228","article-title":"ADCC-mediated CD56DIM NK cell responses are associated with early HBsAg clearance in acute HBV infection","volume":"3","author":"Yu","year":"2018","journal-title":"Pathog Immun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41598-017-00221-9","article-title":"NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv180","article-title":"Natural killer cell characteristics in patients with chronic hepatitis B virus (HBV) infection are associated with HBV surface antigen clearance after combination treatment with pegylated interferon alfa-2a and adefovir","volume":"212","author":"Stelma","year":"2015","journal-title":"J Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.intimp.2018.06.043","article-title":"Recovery of circulating CD56dim NK cells and the balance of Th17\/treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg","volume":"62","author":"Liu","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.12.005","article-title":"T cell immunoglobulin- and mucin-domain-containing molecule-3 (tim-3) mediates natural killer cell suppression in chronic hepatitis B","volume":"52","author":"Ju","year":"2010","journal-title":"J Hepatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1489770","article-title":"Differences in the intrahepatic expression of immune checkpoint molecules on T cells and natural killer cells in chronic HBV patients","volume":"15","author":"Dumolard","year":"2024","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01496.x","article-title":"Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells","volume":"19","author":"Shi","year":"2012","journal-title":"J Viral Hepat"},{"key":"B70","doi-asserted-by":"publisher","first-page":"733.e9","DOI":"10.1016\/j.cmi.2016.05.009","article-title":"Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection","volume":"22","author":"Ghosh","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002594","article-title":"TGF-\u03b21 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence","volume":"8","author":"Sun","year":"2012","journal-title":"PLoS Pathog"},{"key":"B73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.23977","article-title":"Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients","volume":"53","author":"Zhang","year":"2011","journal-title":"Hepatol Baltim Md"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.02.020","article-title":"Liver-specific HBsAg transgenic mice are over-sensitive to poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner","volume":"47","author":"Chen","year":"2007","journal-title":"J Hepatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cei.12597","article-title":"Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection","volume":"180","author":"Zheng","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100980","article-title":"Association of HBsAg levels with differential gene expression in NK, CD8 T, and memory B cells in treated patients with chronic HBV","volume":"6","author":"Beudeker","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12879-020-05233-x","article-title":"Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B","volume":"20","author":"Gu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1053\/j.gastro.2009.05.047","article-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections","volume":"137","author":"Oliviero","year":"2009","journal-title":"Gastroenterology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.07.009","article-title":"Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B","volume":"54","author":"Tjwa","year":"2011","journal-title":"J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i16.1950","article-title":"Immune response pattern varies with the natural history of chronic hepatitis B","volume":"25","author":"Wang","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.antiviral.2017.01.007","article-title":"NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection","volume":"140","author":"de Groen","year":"2017","journal-title":"Antiviral Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12048","article-title":"Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir","volume":"40","author":"Zhao","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12245","article-title":"Effects of entecavir on peripheral blood lymphocyte profiles in chronic hepatitis B patients with suboptimal responses to adefovir","volume":"41","author":"Zhang","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02181-12","article-title":"Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B","volume":"57","author":"Ma","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-017-9803-4","article-title":"Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B","volume":"11","author":"Chen","year":"2017","journal-title":"Hepatol Int"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12946","article-title":"CD56bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long-term entecavir-treated patients switching to peginterferon alfa-2a","volume":"25","author":"Shi","year":"2018","journal-title":"J Viral Hepat"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00421","article-title":"Hepatitis B e antigen induces NKG2A+ natural killer cell dysfunction via regulatory T cell-derived interleukin 10 in chronic hepatitis B virus infection","volume":"8","author":"Ma","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/804043","article-title":"Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients","volume":"2012","author":"Lv","year":"2012","journal-title":"Mediators Inflammation"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.893628","article-title":"Effect of antiviral therapy during pregnancy on natural killer cells in pregnant women with chronic HBV infection","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1116689","article-title":"Changes of natural killer cells\u2019 phenotype in patients with chronic hepatitis B in intermittent interferon therapy","volume":"14","author":"Bi","year":"2023","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1067362","article-title":"Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN \u03b1-2a therapy","volume":"13","author":"Cao","year":"2022","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2178143","article-title":"The characteristics of natural killer cells in chronic hepatitis B patients who received PEGylated-interferon versus entecavir therapy","volume":"2021","author":"Cao","year":"2021","journal-title":"BioMed Res Int"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28155","article-title":"Natural killer cell phenotype modulation and natural killer\/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B","volume":"62","author":"Boni","year":"2015","journal-title":"Hepatol Baltim Md"},{"key":"B97","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.imlet.2014.03.013","article-title":"A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment","volume":"160","author":"Diao","year":"2014","journal-title":"Immunol Lett"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332290","article-title":"HBcrAg values may predict virological and immunological responses to pegIFN-\u03b1 in NUC-suppressed HBeAg-negative chronic hepatitis B","volume":"73","author":"Vecchi","year":"2024","journal-title":"Gut"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/j.gastro.2018.01.030","article-title":"TLR7 agonist increases responses of hepatitis B virus-specific T cells and natural killer cells in patients with chronic hepatitis B treated with nucleos(T)ide analogues","volume":"154","author":"Boni","year":"2018","journal-title":"Gastroenterology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/v13122400","article-title":"Oral selective TLR8 agonist selgantolimod induces multiple immune cell responses in humans","volume":"13","author":"Ayithan","year":"2021","journal-title":"Viruses"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1295","article-title":"Alpha-galactosylceramide in chronic hepatitis B infection: Results from a randomized placebo-controlled phase I\/II trial","volume":"14","author":"Woltman","year":"2009","journal-title":"Antivir Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2019.0042","article-title":"Boosting of hepatitis B virus-specific T cell responses after pegylated-interferon-\u03b1-2a therapy for hepatitis B e antigen-positive pediatric patients","volume":"39","author":"Ning","year":"2019","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0345-y","article-title":"Thymic development of unconventional T cells: How NKT cells, MAIT cells and \u03b3\u03b4 T cells emerge","volume":"20","author":"Pellicci","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf0095","article-title":"Early-life imprinting of unconventional T cells and tissue homeostasis","volume":"374","author":"Constantinides","year":"2021","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101657","article-title":"The multisensory regulation of unconventional T cell homeostasis","author":"Darrigues","year":"2022","journal-title":"Semin Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900774","article-title":"Human mucosal-associated invariant T cells in older individuals display expanded TCR\u03b1\u03b2 clonotypes with potent antimicrobial responses","volume":"204","author":"Loh","year":"2020","journal-title":"J Immunol Baltim Md 1950"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1175147","article-title":"Innate immunity and early liver inflammation","volume":"14","author":"Yang Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.028","article-title":"The role of innate immunity in the immunopathology and treatment of HBV infection","volume":"64","author":"Maini","year":"2016","journal-title":"J Hepatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nature13160","article-title":"T-cell activation by transitory neo-antigens derived from distinct microbial pathways","volume":"509","author":"Corbett","year":"2014","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12021","article-title":"Human blood MAIT cell subsets defined using MR1 tetramers","volume":"96","author":"Gherardin","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.04.009","article-title":"Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells","volume":"71","author":"Dias","year":"2019","journal-title":"J Hepatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31602","article-title":"Mucosal-associated invariant T cell dysregulation correlates with conjugated bilirubin level in chronic HBV infection","volume":"73","author":"Liu","year":"2021","journal-title":"Hepatol Baltim Md"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix425","article-title":"Mucosal-associated invariant T cells are more activated in chronic hepatitis B, but not depleted in blood: Reversal by antiviral therapy","volume":"216","author":"Boeijen","year":"2017","journal-title":"J Infect Dis"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i31.4703","article-title":"Mucosal-associated invariant T cells in hepatitis B virus-related liver failure","volume":"26","author":"Xue","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2903128","article-title":"Chronic viral infection compromises the quality of circulating mucosal-associated invariant T cells and follicular T helper cells via expression of inhibitory receptors","volume":"29","author":"Vimali","year":"2024","journal-title":"Front Biosci Landmark Ed"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00472","article-title":"Hyper-expression of PD-1 is associated with the levels of exhausted and dysfunctional phenotypes of circulating CD161++TCR iV\u03b17.2+ mucosal-associated invariant T cells in chronic hepatitis B virus infection","volume":"9","author":"Yong","year":"2018","journal-title":"Front Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1177\/1753425917714854","article-title":"Decrease of CD69 levels on TCR V\u03b17.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients","volume":"23","author":"Yong","year":"2017","journal-title":"Innate Immun"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13341","article-title":"Mucosal-associated invariant T-cells are severely reduced and exhausted in humans with chronic HBV infection","volume":"27","author":"Huang","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e1073","DOI":"10.1002\/ctm2.1073","article-title":"Biopsy-based single-cell transcriptomics reveals MAIT cells as potential targets for controlling fibrosis-related liver inflammation due to chronic hepatitis-B infection","volume":"12","author":"Shao","year":"2022","journal-title":"Clin Transl Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.19193\/0393-6384_2019_6_527","article-title":"Loss of mucosal-associated invariant T cell in patients with chronic hepatitis B virus-infected cirrhosis","volume":"35","author":"Ju","year":"2019","journal-title":"Acta Med Mediterr"},{"key":"B122","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00281-019-00752-5","article-title":"\u03b3\u03b4 T cells in rheumatic diseases: From fundamental mechanisms to autoimmunity","volume":"41","author":"Nguyen","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u03b3\u03b4 T cells: Origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830210429","article-title":"A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma\/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment","volume":"21","author":"Deusch","year":"1991","journal-title":"Eur J Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4331","article-title":"Homing and function of human skin gammadelta T cells and NK cells: Relevance for tumor surveillance","volume":"176","author":"Ebert","year":"2006","journal-title":"J Immunol Baltim Md 1950"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081787","article-title":"A role for human skin-resident T cells in wound healing","volume":"206","author":"Toulon","year":"2009","journal-title":"J Exp Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/s41467-018-04076-0","article-title":"The human V\u03b42+ T-cell compartment comprises distinct innate-like V\u03b39+ and adaptive V\u03b39- subsets","volume":"9","author":"Davey","year":"2018","journal-title":"Nat Commun"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107773","article-title":"High CD26 and low CD94 expression identifies an IL-23 responsive V\u03b42+ T cell subset with a MAIT cell-like transcriptional profile","volume":"31","author":"Wragg","year":"2020","journal-title":"Cell Rep"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00756","article-title":"Unique and common features of innate-like human V\u03b42+ \u03b3\u03b4T cells and mucosal-associated invariant T cells","volume":"9","author":"Provine","year":"2018","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2665","article-title":"Butyrophilin 3A1 binds phosphorylated antigens and stimulates human \u03b3\u03b4 T cells","volume":"14","author":"Vavassori","year":"2013","journal-title":"Nat Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","article-title":"The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human V\u03b39V\u03b42 T cells","volume":"40","author":"Sandstrom","year":"2014","journal-title":"Immunity"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003501","article-title":"Phosphoantigen\/IL2 expansion and differentiation of V\u03b32V\u03b42 T cells increase resistance to tuberculosis in nonhuman primates","volume":"9","author":"Chen","year":"2013","journal-title":"PLoS Pathog"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1602019","article-title":"Adoptive transfer of phosphoantigen-specific \u03b3\u03b4 T cell subset attenuates mycobacterium tuberculosis infection in nonhuman primates","volume":"198","author":"Qaqish","year":"2017","journal-title":"J Immunol Baltim Md 1950"},{"key":"B134","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40364-025-00762-6","article-title":"Gamma delta T cells and their immunotherapeutic potential in cancer","volume":"13","author":"Cieslak","year":"2025","journal-title":"biomark Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.03.005","article-title":"Activated \u03b3\u03b4 T cells exhibit cytotoxicity and the capacity for viral clearance in patients with acute hepatitis B","volume":"202","author":"Jia","year":"2019","journal-title":"Clin Immunol Orlando Fla"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007715","article-title":"Distinct phenotype and function of circulating V\u03b41+ and V\u03b42+ \u03b3\u03b4T-cells in acute and chronic hepatitis B","volume":"15","author":"Chang","year":"2019","journal-title":"PLoS Pathog"},{"key":"B137","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3892\/etm.2019.8197","article-title":"Increase in liver \u03b3\u03b4 T cells with concurrent augmentation of IFN-\u03b2 production during the early stages of a mouse model of acute experimental hepatitis B virus infection","volume":"19","author":"Chang","year":"2020","journal-title":"Exp Ther Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit312","article-title":"Decreased V\u03b42 \u03b3\u03b4 T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B","volume":"208","author":"Wu","year":"2013","journal-title":"J Infect Dis"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1086\/593065","article-title":"Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): An association between V(delta)2 subtype and chronic HBV infection","volume":"198","author":"Chen","year":"2008","journal-title":"J Infect Dis"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2020.0314","article-title":"Characteristics of circulatory \u03b3\u03b4 T cells in patients with symptomatic chronic hepatitis B infection","volume":"34","author":"Gogoi","year":"2021","journal-title":"Viral Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9678-z","article-title":"Enhanced peripheral \u03b3\u03b4T cells cytotoxicity potential in patients with HBV-associated acute-on-chronic liver failure might contribute to the disease progression","volume":"32","author":"Chen","year":"2012","journal-title":"J Clin Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/imm.13696","article-title":"Serum vitamin D deficiency is associated with increased risk of \u03b3\u03b4 T cell exhaustion in HBV-infected patients","volume":"171","author":"Li","year":"2024","journal-title":"Immunology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12820","article-title":"Unconventional T cells in chronic hepatitis B patients on long-term suppressive therapy with tenofovir followed by a peg-IFN add-on strategy: A randomized study","volume":"25","author":"Cannizzo","year":"2018","journal-title":"J Viral Hepat"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120086","article-title":"Enhanced functions of peripheral \u03b3\u03b4 T cells in chronic hepatitis B infection during interferon \u03b1 treatment in vivo and in vitro","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2018.05.010","article-title":"changes and clinical significance of \u03b3\u03b4T cells in peripheral blood of patients with chronic hepatitis B during pegylated interferon \u03b1-2a treatment","volume":"26","author":"Liu","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi Zhonghua Ganzangbing Zazhi Chin J Hepatol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088475","article-title":"TCR\u03b3\u03b4(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B","volume":"9","author":"Lai","year":"2014","journal-title":"PLoS One"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20102555","article-title":"Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection","volume":"208","author":"Brigl","year":"2011","journal-title":"J Exp Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2012.02750.x","article-title":"Immunomodulatory type II natural killer T lymphocytes in health and disease","volume":"76","author":"Rhost","year":"2012","journal-title":"Scand J Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00314","article-title":"Possible therapeutic application of targeting type II natural killer T cell-mediated suppression of tumor immunity","volume":"9","author":"Kato","year":"2018","journal-title":"Front Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701801","article-title":"Elevated hepatic CD1d levels coincide with invariant NKT cell defects in chronic hepatitis B virus infection","volume":"200","author":"Tan","year":"2018","journal-title":"J Immunol Baltim Md 1950"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-024-09495-4","article-title":"CCR2+TREM-1+\u2009monocytes promote natural killer T cell dysfunction contributing towards HBV disease progression","volume":"72","author":"Wu","year":"2024","journal-title":"Immunol Res"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12299","article-title":"Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-\u03b3 or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection","volume":"22","author":"Conroy","year":"2015","journal-title":"J Viral Hepat"},{"key":"B153","article-title":"phenotypic and functional features of NK and NKT cells in chronic hepatitis B","volume":"31","author":"Wu","year":"2015","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi Chin J Cell Mol Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-015-2539-3","article-title":"Roles of the programmed cell death 1, T cell immunoglobulin mucin-3, and cluster of differentiation 288 pathways in the low reactivity of invariant natural killer T cells after chronic hepatitis B virus infection","volume":"160","author":"Yang","year":"2015","journal-title":"Arch Virol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s12072-015-9650-0","article-title":"The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection","volume":"10","author":"Li","year":"2016","journal-title":"Hepatol Int"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028871","article-title":"Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B","volume":"6","author":"Jiang","year":"2011","journal-title":"PLoS One"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000961","article-title":"Preserved function of circulating invariant natural killer T cells in patients with chronic hepatitis B virus infection","volume":"94","author":"Zhu","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.4238\/2015.May.11.26","article-title":"Changes in peripheral blood natural killer T cells in hepatitis B e antigen-positive chronic hepatitis B patients and efficacy prediction after pegylated interferon therapy","volume":"14","author":"Huang","year":"2015","journal-title":"Genet Mol Res GMR"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07700.x","article-title":"Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins","volume":"98","author":"Safadi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver","volume":"10","author":"Jo","year":"2014","journal-title":"PLoS Pathog"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0780","article-title":"Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0","volume":"31","author":"Wu","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.06.027","article-title":"Phase ib\/IIa randomized study of heterologous ChAdOx1-HBV\/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB","volume":"81","author":"Tak","year":"2024","journal-title":"J Hepatol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.08.010","article-title":"Sequential peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B","volume":"82","author":"Buti","year":"2025","journal-title":"J Hepatol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405485","article-title":"Xalnesiran with or without an immunomodulator in chronic hepatitis B","volume":"391","author":"Hou","year":"2024","journal-title":"N Engl J Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.02.020","article-title":"Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection","volume":"77","author":"Gehring","year":"2022","journal-title":"J Hepatol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jhep.2022.03.028","article-title":"The challenges of adopting immunological biomarkers in the management of chronic HBV infection","volume":"77","author":"Bertoletti","year":"2022","journal-title":"J Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1611976\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:27:06Z","timestamp":1751606826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1611976\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":166,"alternative-id":["10.3389\/fimmu.2025.1611976"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1611976","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"article-number":"1611976"}}